These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9404550)
21. Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women. Cuong DT; My Huong NT Contraception; 1996 Sep; 54(3):169-79. PubMed ID: 8899259 [TBL] [Abstract][Full Text] [Related]
22. Medical contraindications and issues for consideration in the use of once-a-month injectable contraceptives. Dorflinger LJ Contraception; 1994 May; 49(5):455-68. PubMed ID: 8045132 [TBL] [Abstract][Full Text] [Related]
23. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives. Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206 [TBL] [Abstract][Full Text] [Related]
24. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
25. Combination injectable contraceptives for contraception. Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C Cochrane Database Syst Rev; 2013; 3():CD004568. PubMed ID: 23641480 [TBL] [Abstract][Full Text] [Related]
26. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion. el Nahal N; Hassan EO; el Houssinie M Contraception; 1999 Jun; 59(6):369-75. PubMed ID: 10518231 [TBL] [Abstract][Full Text] [Related]
27. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh. Swenson I; Khan AR; Jahan FA Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442 [TBL] [Abstract][Full Text] [Related]
28. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea. Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247 [TBL] [Abstract][Full Text] [Related]
30. Introduction of cyclofem once-a-month injectable contraceptive in Mexico. Garza-Flores J; Moraks del Olmo A; Fuziwara JL; Figueroa JG; Alonso A; Monroy J; Perez M; Urbina-Fuentes M; Guevara SJ; Cedeno E; Barrios R; Ferman JJ; Medina LM; Velazquez E; Perez-Palacios G Contraception; 1998 Jul; 58(1):7-12. PubMed ID: 9743890 [TBL] [Abstract][Full Text] [Related]
31. Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects. Hassan EO; el-Nahal N; el-Hussinie M Contraception; 1999 Aug; 60(2):87-92. PubMed ID: 10592855 [TBL] [Abstract][Full Text] [Related]
32. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa. Smit J; McFadyen L; Zuma K; Preston-Whyte E Soc Sci Med; 2002 Nov; 55(9):1511-22. PubMed ID: 12297238 [TBL] [Abstract][Full Text] [Related]
33. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections. Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615 [TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters. Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019 [TBL] [Abstract][Full Text] [Related]
35. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
37. Maintaining technical quality of care in the introduction of Cyclofem in a national family planning program: findings from Indonesia. Lubis F; Fajans P; Simmons R Contraception; 1994 May; 49(5):527-41. PubMed ID: 8045136 [TBL] [Abstract][Full Text] [Related]